Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
![Opioid crisis: 'You can't put the genie back in the bottle' with the damage done, Harvard professor explains Opioid crisis: 'You can't put the genie back in the bottle' with the damage done, Harvard professor explains](https://s.yimg.com/uu/api/res/1.2/Qgcar1n7d.jKfAYWwkyiOA--~B/Zmk9ZmlsbDtweW9mZj0wO3c9NjQwO2g9MzYwO3NtPTE7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/hd/cp-video-transcode/prod/2022-02/08/6202d12445c76968c3c0bbf2/6202d12445c76968c3c0bbf3_o_U_v2.jpg)
Opioid crisis: 'You can't put the genie back in the bottle' with the damage done, Harvard professor explains
What Kind Of Shareholders Hold The Majority In Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Shares?
![TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance | Teva pharmaceuticals, Pharmaceutical industry, Pharmaceutical TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance | Teva pharmaceuticals, Pharmaceutical industry, Pharmaceutical](https://i.pinimg.com/originals/3f/b6/df/3fb6df20675a087fb151062dd99518b4.png)